Skip to main content

Now we are four

The world is overdue an update on Asa.

Since last we wrote, he's begun capoeira classes, learned to ride a bicycle, and had five doses of chemotherapy drugs injected into his right eye.
 He understands now that other children don't have to go through all of these things; not everyone has poorly eyes. But remarkably, he protests very little. He's easy-going, and he doesn't bear grudges (at least so far).

 

New hope


As a treatment for Rb, the most recent procedure -- intra-vitreal injections of melphalan -- is relatively new. Pioneered by the Japanese, and refined in the US and Switzerland, it's been tried on only about a dozen children in the UK so far.

Since the last dose was given in November, he's had three exams under anaesthetic. The results have been as close to 'all clear' as we've had in the past three years. At each exam, the doctors have seen some new tumour activity in the right eye, but it's been discrete and in a place that's accessible to local treatment (around 6 or 7 o'clock, as the doctors say: towards the bottom of the eye).

This contrasts with the situation before the injections, when there were seeds diffused throughout the eye, threatening to grow out of control.

We're hopeful things are settling down.

 

A new world


In addition to battling this disease -- or playing host to the battle that the doctors are waging in his eyes --  Asa is of course going through the more ordinary dramas of childhood.

Several months ago, he started nursery.

For a few mornings a week at first, and then for full days -- nine to three thirty -- he joined a new society, the confraternity of Other Children.

Asa and his buddy Silas

This is a big transition for any child, but we were particularly curious about how Asa would take it. For most of his life, he'd been living a secluded existence, sheltered from others during the frequent rounds of chemo, and with a fairly small social circle among our neighbours and friends in London.

During the first weeks at nursery, he picked up the names of his classmates and would sometimes speak of them at home. Selam arranged play dates, and he'd play alongside his peers. But not until a couple of months ago did he truly *get* them.

In a period of a week or two, other children came alive for him, as people whose worlds he could step into -- and they into his. This was a great revelation, and now the intensity of interaction, the excitement of shared play, reached fever pitch.

As soon as this is in the past, it's easy to take it all for granted. But for a long time we were hoping and waiting for it, with that special flavour of anxiety characteristic of parents of children with long-term health problems. And when it came we were delighted.

 

A short leash


Our feelings on this are probably also informed by the fact that we have seen more of Asa's childhood than parents whose children are healthy. Selam can still count on one hand the number of times, since he turned one year old that she's been away from Asa for more than six hours at a stretch. And from taking time off work when he was on chemo, and arranging my schedule around hospital visits, I've seen more of him than many dads do.



Today he turns four.

On Saturday a dozen or so of his new friends will pile into the soft play area of the Peckham Leisure Centre to charge around and blow off steam. And then we'll herd them into another room for cake and a song.

We've asked guests not to buy presents (he has too many toys already), but instead to consider a donation for children with eye cancer in Ethiopia, through this website:

https://africanbushtrek2014.everydayhero.com/uk/life-and-sight-for-ethiopia










Comments

Popular posts from this blog

Afterlife

Spring. Bulbs and buds burst into flower. Things come back to life.
Ayya's namesake Anne was born in Spring, in Nashville, Tennessee, on March 25th (also known as Lady Day, or the Annunciation), the day when people in Medieval Europe thought the world began.


What threads connect Anne to Ayya? What affinities, beyond a name, and a fraction of shared genetic material?
As a young woman, Anne lived in Africa for five years. She had just married a Frenchman, Jean-Paul, and accompanied him to Cameroon, where he was to work as a teacher in lieu of military service. She was a new mother at the time (she carried my cousin Miriam with her), and it was there that she gave birth to her second child, Eric.
One of my favourite works of anthropology is a study of infancy in West Africa. Among the Beng of Cote d’Ivoire, children are understood to come from the Afterlife. In their way of thinking, people’s spirits enter a sort of limbo when they die. When babies are born, they gain passage back into l…

Cataract / VI

At about 4 o’clock this afternoon, Asa came around after being under anaesthetic for a cataract operation. It was the first time he’d had surgery – indeed, anything but routine eye exams – for more than a year.
Selam and I felt more anxious than we’d expected to be about this operation. It brought back memories of difficult times. Times – there had been dozens of them – when we waited, with a mixture of fear and hope, for news of how the procedure had gone. There had been a few times when we’d felt we we were close to losing him – like that time when he was on second-line chemo, and I was in Congo, and Selam told me over the phone that his Hickman line was infected. Or that time, during the third course of chemotherapy, when he went into anaphylactic shock.
Compared to those occasions, this cataract operation was low-risk. And, thank goodness, it went smoothly.
As Asa gradually regained consciousness, he put his fingers to the plastic shield taped over his right eye to protect it. Sela…

Blind for a day

My mum likes to say that we learn about our bodies the way we learn about cars -- each time something goes wrong, you get acquainted with a new branch of mechanics.

As various treatments have been tried out on Asa, we've learned more and more about cancer and the eye.

The graph below summarises the treatments Asa's received these past 18 months.



Situations where retinoblastoma fails to respond to both primary and secondarychemo are rare, and even at one of the world's specialist treatment centres, a doctor might see such a case only once every few years.

 Support research on eye cancer here.
Right now we're in a place, therefore, where epidemiology and large trials have ceased to help much, and clinical judgment becomes very important.

As Dr Jenkinson -- the oncologist we met with in Birmingham -- said, "We're beyond the situation where there's a firm evidence base."

What's required then is very close attention to the details of the disease as it'…